News
AAPG
19.00
0.00%
0.00
Ascentage Pharma Corrects Timing for August 19, 2026 Interim Results Webcast
TipRanks · 2d ago
Analysts Have Conflicting Sentiments on These NA Companies: MNTN, Inc Class A (MNTN) and Ascentage Pharma Group International Unsponsored ADR (AAPG)
TipRanks · 5d ago
Weekly Report: what happened at AAPG last week (0803-0807)?
Weekly Report · 5d ago
Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
Barchart · 08/05 07:00
Weekly Report: what happened at AAPG last week (0727-0731)?
Weekly Report · 08/03 09:12
Ascentage Pharma appoints Miyara as CBO, Ziegler as CCO
TipRanks · 08/03 00:00
Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer
Barchart · 08/02 18:30
Ascentage Pharma CEO Dajun Yang Ranked Among Top Small-Molecule Leaders in 2026 Power List
TipRanks · 07/27 20:47
Weekly Report: what happened at AAPG last week (0720-0724)?
Weekly Report · 07/27 09:13
Ascentage Pharma Sets Up US$200 Million Nasdaq ATM Offering Following SEC Shelf Filing
TipRanks · 07/20 12:48
Ascentage Pharma files to sell American Depositary Shares, no amount given
TipRanks · 07/20 10:05
Weekly Report: what happened at AAPG last week (0713-0717)?
Weekly Report · 07/20 09:12
Ascentage Pharma management to meet with B. Riley
TipRanks · 07/16 17:20
Ascentage Pharma Corrects AGM Date Underpinning Equity Incentive Mandate
TipRanks · 07/14 00:48
Weekly Report: what happened at AAPG last week (0706-0710)?
Weekly Report · 07/13 09:12
Weekly Report: what happened at AAPG last week (0629-0703)?
Weekly Report · 07/06 09:13
Weekly Report: what happened at AAPG last week (0622-0626)?
Weekly Report · 06/29 09:12
ON Semiconductor, SanDisk And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
Benzinga · 06/26 12:03
Weekly Report: what happened at AAPG last week (0615-0619)?
Weekly Report · 06/22 09:14
Ascentage Pharma assumed with an Outperform at Oppenheimer
TipRanks · 06/15 11:24
More
Webull provides a variety of real-time AAPG stock news. You can receive the latest news about Ascentage Pharma Group International through multiple platforms. This information may help you make smarter investment decisions.
About AAPG
Ascentage Pharma Group International is an investment holding company primarily engaged in the discovery, development, and commercialization of therapies for hematologic malignancies. The Company's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The Company's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The Company primarily conducts its businesses in domestic market.